Both in Biotechnology
Intensity Therapeutics vs aTyr Pharma
Over the past year INTS returned −78.2% and ATYR returned −81.7%; their daily moves had a correlation of 0.08.
INTS −78.2% ATYR −81.7%Growth of $1, one year, split-adjusted
| Metric | INTS | ATYR |
|---|---|---|
| Price | $3.38 | $6.44 |
| Market cap | $11.0M | $16.1M |
| Today | −1.55% | +2.38% |
| 1 month | −2.1% | −44.5% |
| 6 months | −35.1% | −80.9% |
| Year to date | −67.1% | −79.4% |
| 1 year | −81.5% | −81.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 84.7× |
| Net cash | $9.5M | $56.9M |
| Dividend yield | — | — |
| Volatility (60d) | 62.2% | 1,072.2% |
| Short % of float | 2.9% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).